Linked Life Data

6494244

Source:http://linkedlifedata.com/resource/pubmed/id/6494244

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1984-12-18
pubmed:abstractText
This survey deals with methods to achieve drug safety within the phase IV of psychotropic drug development. Data related to adverse drug reactions (ADRs) are very heterogeneous and have to be collected from very different sources. A sophisticated method, called hospital-based drug monitoring, serves as an important tool for assessment of ADRs in in-patients. The techniques of assessment developed in the context of drug monitoring will be described in detail in this paper. The data obtained may also serve for the evaluation of efficacy and economy of drug treatment in psychiatric in-patients. Moreover, drug monitoring in hospitals may have some value for residents' training in psychiatry, and for generating of hypotheses in clinical pharmacology and biological psychiatry.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0176-3679
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
152-6
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1984
pubmed:articleTitle
Drug safety in psychiatry--an objective for drug monitoring in phase IV.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't